The development of anti-human epidermal growth factor receptor 2(HER2)/anti-tumor associatedfibroblast(TAF)/anti-methoxypolyethylene glycol(mPEG) trispecific antibody to enhance the therapeutic effects of mPEG nanoparticles to breast cancer
碩士 === 臺北醫學大學 === 生藥學研究所 === 106
Main Authors: | Hsin-Yu Chang, 張歆妤 |
---|---|
Other Authors: | Kuo-Hsiang Chuang |
Format: | Others |
Language: | zh-TW |
Published: |
2018
|
Online Access: | http://ndltd.ncl.edu.tw/handle/rzs6gd |
Similar Items
-
Development of a Desktop Bio-Rapid Prototyping System for Fabricating mPEG-PCL-mPEG Scaffolds
by: Yo-Yu Chen, et al.
Published: (2011) -
Mixed Micelles of (R, S)PHB-mPEG and (R)PHB-mPEG as Nano-carrier for Drug Delivery
by: Hao-Feng Sun, et al.
Published: (2016) -
Dataset of working mPEG-alkyne with scCO2
by: S. López, et al.
Published: (2021-04-01) -
The Osteogenesis of Bone Marrow Stem Cells on mPEG-PCL-mPEG/Hydroxyapatite Composite Scaffold via Solid Freeform Fabrication
by: Han-Tsung Liao, et al.
Published: (2014-01-01) -
Enhancement of tumor tropism of mPEGylated nanoparticles by anti-mPEG bispecific antibody for ovarian cancer therapy
by: Wen-Wei Lin, et al.
Published: (2021-04-01)